NCBI » Bookshelf » Genes and Disease » Autoimmune polyglandular syndrome
 
gnd
Genes and Disease
Laura Dean1 and Jo McEntyre1
National Center for Biotechnology Information (NCBI), National Library of Medicine, National Institutes of Health, Bethesda, MD 20892-6510
National Center for Biotechnology Information (NCBI)2007
medical genetics

Autoimmune polyglandular syndrome

autoimmunepolyglandularsyndrome

The endocrine system is responsible for the release of hormones into the blood or lymph. Deficiencies in the endocrine system can be caused by infection, infarction, or a tumor destroying all or a large part of the gland. However, the activity of an endocrine organ is most often depressed as a result of an autoimmune reaction that ultimately results in partial or complete destruction of the gland. Autoimmune disease affecting one organ is frequently followed by the impairment of other glands, resulting in multiple endocrine failure.

Autoimmune polyglandular syndrome type I (APS1, also called APECED) is a rare autosomal recessive disorder that maps to human chromosome 21. At the end of 1997, researchers reported that they isolated a novel gene, which they called AIRE (autoimmune regulator). Database searches revealed that the protein product of this gene is a transcription factor—a protein that plays a role in the regulation of gene expression. The researchers showed that mutations in this gene are responsible for the pathogenesis of APS1.

The identification of the gene defective in APS1 is the first step toward developing tests that will be able to genetically diagnose the disease. Further investigations of the gene and its function should also facilitate finding a potential treatment for the disease as well as increasing our general understanding of the mechanisms underlying other autoimmune diseases.

Help ǀ Contact Bookshelf
Genes and Disease2007
(navigation arrows) Go to previous chapter Go to next chapter Go to top of this page Go to bottom of this page Go to Table of Contents